Review of New and Emerging Therapies that Improve Tolerability and Adherence in Patients with Relapsing Multiple Sclerosis

Mar 23, 2024

- Mar 22, 2025

0.75

Claim your AMA PRA Category 1 Credit

This course is available for logged in users only. Please login or register to take the course.

ASH2025 Update on Management of Anemia in Patients with Myelofibrosis

Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists

The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patient...